[SALE] Global Database of Regenerative Medicine (RM) Industry Investors – Featuring 300+ Investors

Description

The world’s only searchable, sortable database of 300+ investors who are actively investing in regenerative medicine (RM) and advanced therapy (AT) companies.

For 48 hours only, you can claim this database for 50% off. 

Regenerative medicine companies are defined as those involved with cell therapies, gene therapies, exosomes, tissue engineering, biomaterials, or other related therapies involving the use of human cells and tissues.

Gene therapy is the use of genetic material to change the expression of a gene product, while cell therapies utilize living cells to create either direct or indirect effects within the human body. Exosomes exert their effects by carrying cell-specific cargos which are selectively taken up by recipient cells. Likewise, there are technologies that can impact the health of tissues and organs through the use of biomaterials, tissue engineering, and 3D bioprinting.

To develop these novel regenerative medicine (RM) and advanced therapy (AT) products, investor capital is often needed to support these therapeutics from preclinical development through clinical trials, and ultimately, to commercialization.

Regenerative medicine industry investors include:

• Venture Capital Groups
• Private Equity Firms
• Hedge Funds
• Investment Firms
• Endowment Funds
• Family Offices
• Angel Investors (for example, Tony Robbins, Bill Maris, Peter Diamandis and others)

Database of Regenerative Medicine (RM) Investors

This database reveals the identity and investment behavior of over 300 investors who specialize in companies commercializing regenerative medicine (RM) and advanced therapy (AT) products.

This database has compiled over several years, using the regenerative medicine (RM) and advanced therapy (AT) industry relationships our leadership has developed since BioInformant was founded in 2006. As you can imagine, we regularly crowd-source feedback from BioInformant’s partners, clients, colleagues, and readership, as well as utilize translators as necessary. 

Thus, this database includes little known investors that would be difficult to identify if you had not been tracking this industry daily for the past 19+ years (as BioInformant has done).

Best of all, you don’t have to worry about AI errors or inaccuracies. If you want immediate and actionable insights from a trusted, U.S. based provider that specializes exclusively in cell therapy market insights, then this database is for you.

This comprehensive global database includes the following in searchable, sortable format:

1. Investor Identity (Individual or Company Name)
2. Type of Investor
3. Year Founded
4. City/State
5. Country
6. Company Website
7. Regenerative Medicine (RM) Companies Funded
8. Description of the Investor
9. Phone Number
10. Email Address

Use this database if you plan to pursue:

• Seed rounds
• Venture or financing rounds
• Private placements
• Loans and convertible debt
• Any activity requiring external funding

It can also be used to strengthen your network by identifying the regenerative medicine (RM) industry’s most influential investors. Imagine being immediately informed about investor profiles and preferences, without having to conduct research or validate its accuracy.

If you are in the process of raising investor capital for your company, product candidate, or clinical trial, then this database is a must-have.

Format: Excel File (Delivered Instantly)
No. of Companies: 319 Total
Last Updated: May 4, 2026

For 48 hours only, you can claim this database for an unusual $150 off. Act fast, because this offer expires tomorrow!

Of course, your investment is backed by a Greater than 100% Money Back Guarantee. Or, explore the rest of the BioInformant Shop.